US 12,112,834 B2
System and method for non-invasive quantification of blood biomarkers
Marcelo Adorni Pereira, Charneca da Caparica (PT)
Assigned to Refana, Inc., Las Vegas, NV (US)
Filed by Refana Inc., Las Vegas, NV (US)
Filed on Jul. 25, 2023, as Appl. No. 18/358,655.
Application 18/358,655 is a continuation of application No. 17/929,804, filed on Sep. 6, 2022, granted, now 11,742,059.
Prior Publication US 2024/0079093 A1, Mar. 7, 2024
Int. Cl. G16B 40/10 (2019.01); G01N 33/49 (2006.01); G06F 18/214 (2023.01); G06N 20/00 (2019.01)
CPC G16B 40/10 (2019.02) [G01N 33/49 (2013.01); G06F 18/214 (2023.01); G06N 20/00 (2019.01); G01N 2800/60 (2013.01)] 15 Claims
OG exemplary drawing
 
1. A method for determining levels of blood biomarkers implemented by a processor and memory circuitry (PMC), comprising:
(a) providing near infra-red spectrogram data of a patient's living tissue;
(b) using one or more pre-trained prediction models comprising a selected number of prediction routes for processing the near infra-red spectrogram data, and determining accordingly prediction data on a selected group of biomarkers;
(c) determining one or more biomarkers associated with a number of groups, and determining for the one or more biomarkers an average concentration data of said one or more biomarkers in accordance with output data of a number of prediction routes associated with said number of groups; and
(d) generating output data indicative of estimated levels of a selected set of biomarkers for said patient.